FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,495,826 | +30.9% | 562,123 | -2.7% | 0.01% | +40.0% |
| Q2 2023 | $1,906,958 | +3.0% | 577,866 | -11.1% | 0.01% | 0.0% |
| Q1 2023 | $1,851,959 | +91.2% | 649,810 | +388.5% | 0.01% | +66.7% |
| Q4 2022 | $968,378 | -7.9% | 133,019 | -38.1% | 0.00% | 0.0% |
| Q2 2022 | $1,052,000 | +163.0% | 214,763 | +1170.8% | 0.00% | +200.0% |
| Q1 2022 | $400,000 | -95.7% | 16,900 | -96.8% | 0.00% | -95.0% |
| Q4 2021 | $9,216,000 | -48.4% | 520,990 | -17.6% | 0.02% | -50.0% |
| Q3 2021 | $17,844,000 | +10780.5% | 632,539 | +3951.9% | 0.04% | – |
| Q2 2021 | $164,000 | -0.6% | 15,611 | +11.7% | 0.00% | – |
| Q1 2021 | $165,000 | -49.1% | 13,979 | -49.4% | 0.00% | -100.0% |
| Q4 2020 | $324,000 | +256.0% | 27,647 | +140.4% | 0.00% | – |
| Q3 2020 | $91,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |